{"result": "(\"entity\"<|>INSULINA<|>EVENT<|>Insulin is a hormone used in the treatment of diabetes, which the patient is currently using to manage their blood glucose levels.)\n##\n(\"entity\"<|>ANÁLISIS<|>EVENT<|>The analysis refers to the various medical tests conducted to monitor the patient's glucose levels and overall health.)\n##\n(\"entity\"<|>PESO<|>EVENT<|>Weight is a critical measurement for the patient, indicating their nutritional status and response to treatment.)\n##\n(\"entity\"<|>TALLA<|>EVENT<|>Height is another important measurement for the patient, used to assess growth and development in relation to their age and condition.)\n##\n(\"entity\"<|>IMC<|>EVENT<|>Body Mass Index (BMI) is a calculation used to assess the patient's body weight in relation to their height, indicating nutritional status.)\n##\n(\"entity\"<|>PAUTA NUTRICIONAL<|>EVENT<|>Nutritional guidelines provided to the patient to ensure adequate caloric and protein intake for managing their conditions.)\n##\n(\"entity\"<|>ACETATO DE MEGESTROL<|>EVENT<|>Megestrol acetate is a medication prescribed to the patient to stimulate appetite and improve nutritional intake.)\n##\n(\"relationship\"<|>PACIENTE<|>INSULINA<|>The patient is using insulin to manage their diabetes effectively.<|>8)\n##\n(\"relationship\"<|>PACIENTE<|>ANÁLISIS<|>The patient has undergone various analyses to monitor their health status and manage their diabetes and cystic fibrosis.<|>7)\n##\n(\"relationship\"<|>PACIENTE<|>PESO<|>The patient's weight is being monitored as part of their treatment for malnutrition and cystic fibrosis.<|>8)\n##\n(\"relationship\"<|>PACIENTE<|>TALLA<|>The patient's height is measured to assess growth and development in relation to their health conditions.<|>7)\n##\n(\"relationship\"<|>PACIENTE<|>IMC<|>The patient's BMI is calculated to evaluate their nutritional status and the effectiveness of their treatment plan.<|>8)\n##\n(\"relationship\"<|>PACIENTE<|>PAUTA NUTRICIONAL<|>The nutritional guidelines are tailored for the patient to address their specific dietary needs due to cystic fibrosis and diabetes.<|>9)\n##\n(\"relationship\"<|>PACIENTE<|>ACETATO DE MEGESTROL<|>The patient is prescribed megestrol acetate to help increase their appetite and caloric intake.<|>6)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: GE ni náuseas ni\nvómitos ni dolor abdominal. Esteatorrea casi diaria: 3-4 deposiciones al día, pastosas, a\npesar de la correcta cumplimentación de las enzimas pancreáticas.\n\n\n\n         Historia diabetológica:\n         Diabetes Relacionada con la Fibrosis Quística (DRFQ) desde los 14 años, insuli-\nnizada desde el inicio. Mal control glucémico de forma habitual (HbA1c siempre >8,5%).\nNiega complicaciones crónicas de su diabetes.\n\n\n\n         Pauta actual de insulina: Insulina glargina 100UI/ml: 18 UI por la noche, e insulina\nlispro 100UI/ml solo si precisa.\n\n\n\n         No aporta controles de GD. Refiere que son en torno a 150-180mg/dL preprandiales.\nNo hace postprandiales. Duda sobre cómo ajustar la insulin basal, por lo que no suele\nmodificar la dosis.\n\n\n\n         Exploración física:\n         Escaso panículo adiposo.\n         No edemas en MMII.\n         Desarrollo puberal completo: Tanner 4.\n         Portador de gastrostomía tipo botón, con buen aspecto, sin signos de infección\n         (último recambio hace un mes).\n\n\n\n                                                                                               119\n---\n               Antropometría:\n               Talla medida: 152,5cm.\n               Talla diana: 168,5cm +/- 8cm (160,5-176,5cm).\n               Peso: 38,75kg, IMC: 16,7kg/m2.\n               CB: 18cm (<p10), PT: 1mm (<p10), PMB: 17,7(<p10).\n               Peso ideal: 53,5kg (IMC: 23kg/m2 ).\n               Cálculo de requerimientos (Harris Benedict) para peso ideal:\n                      • Calóricos: 1472 * FA 1,4        * FE 1,5 = 3091kcal.\n                      • Proteicos: 53,5 * 1,5 = 80,25 g de proteínas.\n\n\n\n               Exploraciones complementarias:\n               Análisis que aporta el paciente: glucosa: 113mg/dL, HbA1c: 8,1%, función renal\n     normal, CT: 128mg/dL, PT: 7,5g/dL, albúmina: 4,5g/dL, prealbúmina: 17,5mg/dL, Hemograma\n     normal (Hb: 16.4g/dL), Ferritina, vitamina B12 y ácido fólico normales. Vitamina A, E y D\n     no determinadas.\n\n\n\n               Diagnósticos:\n             •Fibrosis quística.\n             •Desnutrición calórica crónica grave (cumple 2 criterios fenotípicos y 2 criterios\n             etiológicos).\n             •Portador de gastrostomía de alimentación para NE nocturna.\n             •Retraso del crecimiento.\n             •Diabetes relacionada con la fibrosis quistica, mal controlada.\n\n\n\n               Tratamiento establecido en la primera visita:\n               Pauta nutricional:\n             •Via oral:\n                   »  Dieta   equilibrada,      hipercalórica,     hiperproteica       para   diabéticos  (con  HC\n                   complejos) de 2500kcal, con 5-6 comidas al día. Se entregan consejos para\n                   aumentar el contenido de Kcal de la dieta.\n                   »  Se pautan suplementos orales hipercalóricos (1,5kcal/ml) hiperproteicos\n                   específicos para diabéticos, 2 al día.\n             •Por gastrostomía: formula polimérica normocalórica (1,0kcaL/ml) normoproteica\n             específica de diabético, 750mL a pasar de forma nocturna en 8horas a 94ml/h.\n             •Se ajusta tratamiento enzimático (a la espera de cita con Gastroenterología):\n             Pancretina 25.000: 2(De)-1(Al)-2(Co)-1(Me)-2(Ce)-2(antes NE)–2(tras la NE) --> en\n             total: 12 comp --> 300.000UI de lipasa/día --> 7900UI/kg/dia.\n\n\n\n120\n---\n         Pauta de insulina:\n         Se enseñan ajustes de insulina basal. Se entrega pauta móvil de insulina rápida\ny se le recomienda realizar controles de GD pre y postprandiales.\n\n\n\n         Evolución:\n         La evolución del peso, talla, IMC así como control glucémico del paciente y las\ndiferentes pautas de NE empleadas se recogen en la Tabla 1.\n\n\n\n         En el año 2011, se pautó acetato de megestrol para aumentar el apetito.\n\n\n\n         En el año 2012, el paciente refería más apetito con la toma del acetato de me-\ngestrol, había aumentado la ingesta oral (el recordatorio de 24h arrojaba una ingesta\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>FIBROSIS QUÍSTICA<|>EVENT<|>Fibrosis quística is a genetic disorder that affects the lungs and digestive system, leading to severe respiratory and nutritional issues.)\n##\n(\"entity\"<|>DIABETES RELACIONADA CON LA FIBROSIS QUÍSTICA<|>EVENT<|>Diabetes related to cystic fibrosis is a common complication that affects glucose metabolism in patients with cystic fibrosis.)\n##\n(\"entity\"<|>GASTROSTOMÍA<|>EVENT<|>Gastrostomy is a surgical procedure to create an opening in the stomach for feeding, which is necessary for patients with severe nutritional deficiencies.)\n##\n(\"entity\"<|>PACIENTE<|>PERSON<|>The patient is a 14-year-old individual diagnosed with cystic fibrosis and diabetes, experiencing chronic malnutrition and requiring specialized dietary management.)\n##\n(\"entity\"<|>HOSPITAL<|>ORGANIZATION<|>The hospital provides medical care and treatment for patients with complex conditions such as cystic fibrosis and diabetes.)\n##\n(\"relationship\"<|>PACIENTE<|>FIBROSIS QUÍSTICA<|>The patient has been diagnosed with cystic fibrosis, which significantly impacts their health and treatment plan.<|>9)\n##\n(\"relationship\"<|>PACIENTE<|>DIABETES RELACIONADA CON LA FIBROSIS QUÍSTICA<|>The patient suffers from diabetes related to cystic fibrosis, complicating their overall health management.<|>8)\n##\n(\"relationship\"<|>PACIENTE<|>GASTROSTOMÍA<|>The patient is a carrier of a gastrostomy for nocturnal feeding due to severe malnutrition.<|>7)\n##\n(\"relationship\"<|>HOSPITAL<|>PACIENTE<|>The hospital is responsible for the medical care and treatment of the patient with cystic fibrosis and diabetes.<|>8)\n<|COMPLETE|>"}]}